4 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-21-006601
Form type: Form 4
Filer: Adamas Pharmaceuticals Inc
CIK: CIK 1328143
Filed: Feb 01, 2021
Reporting period: Feb 01, 2021
Description: Insider transaction

Documents

0001209191-21-006601-index.htm

Complete submission

0001209191-21-006601.txt

directory listing

Filed by

Adamas Pharmaceuticals Inc